Rexahn Pharmaceuticals Inc (RNN.A)

RNN.A on American Stock Exchange

0.81USD
11 Jul 2014
Price Change (% chg)

$-0.02 (-2.87%)
Prev Close
$0.83
Open
$0.83
Day's High
$0.83
Day's Low
$0.81
Volume
126,034
Avg. Vol
225,609
52-wk High
$1.85
52-wk Low
$0.36

RNN.A

Chart for RNN.A

About

Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company’s pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development.... (more)

Overall

Beta: 1.20
Market Cap (Mil.): $143.08
Shares Outstanding (Mil.): 176.64
Dividend: --
Yield (%): --

Financials

  RNN.A Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -0.15 -- --
ROI: -85.78 -0.70 18.27
ROE: -123.98 -1.57 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks